Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination

mBio

Volumn 6, Issue 2, 2015, Pages

  Jensen, Kirk D C ^a,f   Camejo, Ana ^a   Melo, Mariane B ^a   Cordeiro, Cynthia ^a   Julien, Lindsay ^a   Grotenbreg, Gijsbert M ^b   Frickel, Eva Maria ^c   Ploegh, Hidde L ^d   Young, Lucy ^e   Saeij, Jeroen P J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^e MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; IMMUNITY REGULATED GUANOSINE TRIPHOSPHATASE; ROP5 PROTEIN; ROP8 PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; PROTOZOAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; GENETIC VARIABILITY; HOST SUSCEPTIBILITY; MOUSE; NONHUMAN; OUTCROSSING; PARASITE VIRULENCE; POPULATION STRUCTURE; PRIORITY JOURNAL; REINFECTION; SECONDARY INFECTION; STRAIN DIFFERENCE; SUPERINFECTION; TOXOPLASMOSIS; ALLELE; ANIMAL; ANIMAL TOXOPLASMOSIS; C57BL MOUSE; GENETICS; MIXED INFECTION; NORTH AMERICA; PARASITOLOGY; PATHOGENICITY; SOUTH AMERICA; TOXOPLASMA; VIRULENCE;

ANIMALIA; FELIDAE; MUS; TOXOPLASMA; TOXOPLASMA GONDII; VERTEBRATA;

ALLELES; ANIMALS; COINFECTION; MICE, INBRED C57BL; NORTH AMERICA; PROTOZOAN PROTEINS; SOUTH AMERICA; SUPERINFECTION; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VIRULENCE;

EID: 84929492698     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02280-14     Document Type: Article

References (104)

1. Waldeland H, Frenkel JK. 1983. Live and killed vaccines against toxoplasmosis in mice. J Parasitol 69:60–65.http://dx.doi.org/10.2307/3281275.
2. Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A. 1992. Simultaneous depletion of CD4_ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149:175–180.
3. Dubey JP. 2010. Toxoplasmosis of animals and humans, 2nd ed. CRC Press, Taylor & Francis Group, Boca Raton, FL.
4. Sibley LD, Ajioka JW. 2008. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu Rev Microbiol 62:329–351.http://dx.doi.org/10.1146/annurev.micro.62.081307.162925.
5. Shwab EK, Zhu XQ, Majumdar D, Pena HF, Gennari SM, Dubey JP, Su C. 2014. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology 141: 453–461.http://dx.doi.org/10.1017/S0031182013001844.
6. Dubey JP, Velmurugan GV, Rajendran C, Yabsley MJ, Thomas NJ, Beckmen KB, Sinnett D, Ruid D, Hart J, Fair PA, McFee WE, Shearn- Bochsler V, Kwok OC, Ferreira LR, Choudhary S, Faria EB, Zhou H, Felix TA, Su C. 2011. Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int J Parasitol 41:1139–1147.http://dx.doi.org/10.1016/j.ijpara.2011.06.005.
7. Rajendran C, Su C, Dubey JP. 2012. Molecular genotyping of Toxoplasma gondii from Central and South America revealed high diversity within and between populations. Infect Genet Evol 12:359–368.http://dx.doi.org/10.1016/j.meegid.2011.12.010.
8. Minot S, Melo MB, Li F, Lu D, Niedelman W, Levine SS, Saeij JP. 2012. Admixture and recombination among Toxoplasma gondii lineages explain global genome diversity. Proc Natl Acad Sci U S A 109: 13458–13463.http://dx.doi.org/10.1073/pnas.1117047109.
9. Ferreira Ade M, Vitor RW, Gazzinelli RT, Melo MN. 2006. Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP. Infect Genet Evol 6:22–31.http://dx.doi.org/10.1016/j.meegid.2004.12.004.
10. Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, Dardé ML, Zhu XQ, Ajioka JW, Rosenthal BM, Dubey JP, Sibley LD. 2012. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci U S A 109:5844–5849.http://dx.doi.org/10.1073/pnas.1203190109.
11. Parameswaran N, Thompson RC, Sundar N, Pan S, Johnson M, Smith NC, Grigg ME. 2010. Non-archetypal type II-like and atypical strains of Toxoplasma gondii infecting marsupials of Australia. Int J Parasitol 40: 635–640.http://dx.doi.org/10.1016/j.ijpara.2010.02.008.
12. Lehmann T, Graham DH, Dahl ER, Bahia-Oliveira LM, Gennari SM, Dubey JP. 2004. Variation in the structure of Toxoplasma gondii and the roles of selfing, drift, and epistatic selection in maintaining linkage disequilibria. Infect Genet Evol 4:107–114.http://dx.doi.org/10.1016/j.meegid.2004.01.007.
13. Wendte JM, Miller MA, Lambourn DM, Magargal SL, Jessup DA, Grigg ME. 2010. Self-mating in the definitive host potentiates clonal outbreaks of the apicomplexan parasites sarcocystis neurona and Toxoplasma gondii. PLoS Genet 6:e1001261.http://dx.doi.org/10.1371/journal.pgen.1001261.
14. Jenkins CN, Pimm SL, Joppa LN. 2013. Global patterns of terrestrial vertebrate diversity and conservation. Proc Natl Acad Sci U S A 110: E2602–E2610.http://dx.doi.org/10.1073/pnas.1302251110.
15. Kim BH, Shenoy AR, Kumar P, Bradfield CJ, MacMicking JD. 2012. IFN-inducible GTPases in host cell defense. Cell Host Microbe 12: 432–444.http://dx.doi.org/10.1016/j.chom.2012.09.007.
16. Haldar AK, Saka HA, Piro AS, Dunn JD, Henry SC, Taylor GA, Frickel EM, Valdivia RH, Coers J. 2013. IRG and GBP host resistance factors target aberrant, “non-self” vacuoles characterized by the missing of “self” IRGM proteins. PLoS Pathog 9:e1003414.http://dx.doi.org/10.1371/journal.ppat.1003414.
17. Hunn JP, Koenen-Waisman S, Papic N, Schroeder N, Pawlowski N, Lange R, Kaiser F, Zerrahn J, Martens S, Howard JC. 2008. Regulatory interactions between IRG resistance GTPases in the cellular response to Toxoplasma gondii. EMBO J 27:2495–2509.http://dx.doi.org/10.1038/emboj.2008.176.
18. Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Würthner J, Kurig S, Beer S, Pfeffer K. 2007. Extensive characterization of IFNinduced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol 179:7729–7740.http://dx.doi.org/10.4049/jimmunol.179.11.7729.
19. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC. 2005. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1:e24.http://dx.doi.org/10.1371/journal.ppat.0010024.
20. Ling YM, Shaw MH, Ayala C, Coppens I, Taylor GA, Ferguson DJ, Yap GS. 2006. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J Exp Med 203:2063–2071.http://dx.doi.org/10.1084/jem.20061318.
21. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DC, Soldati- Favre D, Horie K, Takeda J, Takeda K. 2012. A cluster of interferongamma- inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37:302–313.http://dx.doi.org/10.1016/j.immuni.2012.06.009.
22. Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klümpers V, Lahme S, Wischmann E, Mausberg AK, Beer-Hammer S, Pfeffer K. 2013. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc Natl Acad Sci U S A 110:294–299.http://dx.doi.org/10.1073/pnas.1205635110.
23. Steinfeldt T, Könen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, Sibley LD, Hunn JP, Howard JC. 2010. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol 8:e1000576.http://dx.doi.org/10.1371/journal.pbio.1000576.
24. Khaminets A, Hunn JP, Könen-Waisman S, Zhao YO, Preukschat D, Coers J, Boyle JP, Ong YC, Boothroyd JC, Reichmann G, Howard JC. 2010. Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell Microbiol 12:939–961.http://dx.doi.org/10.1111/j.1462-5822.2010.01443.x.
25. Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, Fox BA, Bzik DJ, Taylor GA, Turk BE, Lichti CF, Townsend RR, Qiu W, Hui R, Beatty WL, Sibley LD. 2010. Phosphorylation of immunityrelated GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8:484–495.http://dx.doi.org/10.1016/j.chom.2010.11.005.
26. Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Farid Arenas A, Melo MB, Spooner E, Yaffe MB, Saeij JP. 2012. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 8:e1002784.http://dx.doi.org/10.1371/journal.ppat.1002784.
27. Fleckenstein MC, Reese ML, Könen-Waisman S, Boothroyd JC, Howard JC, Steinfeldt T. 2012. A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biol 10:e1001358.http://dx.doi.org/10.1371/journal.pbio.1001358.
28. Behnke MS, Fentress SJ, Mashayekhi M, Li LX, Taylor GA, Sibley LD. 2012. The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18. PLoS Pathog 8:e1002992.http://dx.doi.org/10.1371/journal.ppat.1002992.
29. Etheridge RD, Alaganan A, Tang K, Lou HJ, Turk BE, Sibley LD. 2014. The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 1 5:537–550. http://dx.doi.org/10.1016/j.chom.2014.04.002.
30. Alaganan A, Fentress SJ, Tang K, Wang Q, Sibley LD. 2014. Toxoplasma GRA7 effector increases turnover of immunity-related GTPases and contributes to acute virulence in the mouse. Proc Natl Acad Sci U S A 111:1126–1131.http://dx.doi.org/10.1073/pnas.1313501111.
31. Selleck EM, Fentress SJ, Beatty WL, Degrandi D, Pfeffer K, Virgin HW, Macmicking JD, Sibley LD. 2013. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog 9:e1003320.http://dx.doi.org/10.1371/journal.ppat.1003320.
32. Reese ML, Shah N, Boothroyd JC. 2014. The Toxoplasma pseudokinase rop5 is an allosteric inhibitor of the immunity-related GTPases. J Biol Chem 289:27849–27858.http://dx.doi.org/10.1074/jbc.M114.567057.
33. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP. 2011. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci U S A 108:9625–9630.http://dx.doi.org/10.1073/pnas.1015980108.
34. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, Beatty WL, Hajj HE, Jerome M, Behnke MS, White M, Wootton JC, Sibley LD. 2006. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314:1776–1780.http://dx.doi.org/10.1126/science.1133643.
35. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, Ajioka JW, Boothroyd JC. 2006. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314:1780–1783.http://dx.doi.org/10.1126/science.1133690.
36. Jensen KD, Hu K, Whitmarsh RJ, Hassan MA, Julien L, Lu D, Chen L, Hunter CA, Saeij JP. 2013. Toxoplasma rhoptry kinase ROP16 promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15. Infect Immun 81: 2156–2167.http://dx.doi.org/10.1128/IAI.01185-12.
37. Fux B, Nawas J, Khan A, Gill DB, Su C, Sibley LD. 2007. Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation. Infect Immun 75:2580–2590.http://dx.doi.org/10.1128/IAI.00085-07.
38. Gigley JP, Bhadra R, Khan IA. 2011. CD8 T cells and Toxoplasma gondii: a new paradigm. J Parasitol Res 2011:243796.http://dx.doi.org/10.1155/2011/243796.
39. Suzuki Y, Conley FK, Remington JS. 1989. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol 143:2045–2050.
40. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A. 1991. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146:286–292.
41. Gigley JP, Fox BA, Bzik DJ. 2009. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication. J Immunol 182:1069–1078.http://dx.doi.org/10.4049/jimmunol.182.2.1069.
42. Jordan KA, Wilson EH, Tait ED, Fox BA, Roos DS, Bzik DJ, Dzierszinski F, Hunter CA. 2009. Kinetics and phenotype of vaccine-induced CD8_ T-cell responses to Toxoplasma gondii. Infect Immun 77: 3894–3901.http://dx.doi.org/10.1128/IAI.00024-09.
43. Suzuki Y, Remington JS. 1988. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol 140:3943–3946.
44. Denkers EY, Scharton-Kersten T, Barbieri S, Caspar P, Sher A. 1996. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection. J Exp Med 184:131–139.http://dx.doi.org/10.1084/jem.184.1.131.
45. Casciotti L, Ely KH, Williams ME, Khan IA. 2002. CD8_ T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4_ T cells. Infect Immun 70:434–443.http://dx.doi.org/10.1128/IAI.70.2.434-443.2002.
46. Wilson DC, Matthews S, Yap GS. 2008. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii infection. J Immunol 180: 5935–5945.http://dx.doi.org/10.4049/jimmunol.180.9.5935.
47. Jordan KA, Dupont CD, Tait ED, Liou HC, Hunter CA. 2010. Role of the NF-+B transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii. Int Immunol 22:851–861.http://dx.doi.org/10.1093/intimm/dxq439.
48. Schlüter D, Kwok LY, Lütjen S, Soltek S, Hoffmann S, Körner H, Deckert M. 2003. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J Immunol 170: 6172–6182.http://dx.doi.org/10.4049/jimmunol.170.12.6172.
49. Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, Caspar P, Heiny S, Sher A. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159: 1903–1908.
50. Khan IA, Matsuura T, Kasper LH. 1998. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J Immunol 161:2994–3000.
51. Scharton-Kersten TM, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185: 1261–1273.http://dx.doi.org/10.1084/jem.185.7.1261.
52. Suzuki Y, Wang X, Jortner BS, Payne L, Ni Y, Michie SA, Xu B, Kudo T, Perkins S. 2010. Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+T cells.AmJ Pathol 176:1607–1613.http://dx.doi.org/10.2353/ajpath.2010.090825.
53. Smith DD, Frenkel JK. 2003. Immunological comparison of 124 isolates of Toxoplasma gondii. Parasitol Res 91:332–337.http://dx.doi.org/10.1007/s00436-003-0886-6.
54. Franco PS, Silva DA, Costa IN, Gomes AO, Silva AL, Pena JD, Mineo JR, Ferro EA. 2011. Evaluation of vertical transmission of Toxoplasma gondii in Calomys callosus model after reinfection with heterologous and virulent strain. Placenta 32:116–120.http://dx.doi.org/10.1016/j.placenta.2010.11.012.
55. Khan A, Böhme U, Kelly KA, Adlem E, Brooks K, Simmonds M, Mungall K, Quail MA, Arrowsmith C, Chillingworth T, Churcher C, Harris D, Collins M, Fosker N, Fraser A, Hance Z, Jagels K, Moule S, Murphy L, O’Neil S, Rajandream MA, Saunders D, Seeger K, Whitehead S, Mayr T, Xuan X, Watanabe J, Suzuki Y, Wakaguri H, Sugano S, Sugimoto C, Paulsen I, Mackey AJ, Roos DS, Hall N, Berriman M, Barrell B, Sibley LD, Ajioka JW. 2006. Common inheritance of chromosome Ia associated with clonal expansion of Toxoplasma gondii. Genome Res 16:1119–1125.http://dx.doi.org/10.1101/gr.5318106.
56. Freyre A, Falcón J, Méndez J, Rodriguez A, Correa L, Gonzalez M. 2006. Toxoplasma gondii: partial cross-protection among several strains of the parasite against congenital transmission in a rat model. Exp Parasitol 112:8–12.http://dx.doi.org/10.1016/j.exppara.2005.08.009.
57. Werner H, Janitschke K, Masihi M, Adusu E. 1977. The effect of toxoplasma antibodies after reinfection with T. gondii. III. Communication: investigations on the question of placental transmission of Toxoplasma in immunised pregnant animals. Zentralbl Bakteriol 238:128–142.
58. Araujo F, Slifer T, Kim S. 1997. Chronic infection with Toxoplasma gondii does not prevent acute disease or colonization of the brain with tissue cysts following reinfection with different strains of the parasite. J Parasitol 83:521–522.http://dx.doi.org/10.2307/3284421.
59. Dao A, Fortier B, Soete M, Plenat F, Dubremetz JF. 2001. Successful reinfection of chronically infected mice by a different Toxoplasma gondii genotype. Int J Parasitol 31:63–65.http://dx.doi.org/10.1016/S0020-7519(00)00151-X.
60. Brandão GP, Melo MN, Caetano BC, Carneiro CM, Silva LA, Vitor RW. 2011. Susceptibility to re-infection in C57BL/6 mice with recombinant strains of Toxoplasma gondii. Exp Parasitol 128:433–437.http://dx.doi.org/10.1016/j.exppara.2011.05.015.
61. Brandão GP, Melo MN, Gazzinelli RT, Caetano BC, Ferreira AM, Silva LA, Vitor RW. 2009. Experimental reinfection of BALB/c mice with different recombinant type I/III strains of Toxoplasma gondii: involvement of IFN-gamma and IL-10. Mem Inst Oswaldo Cruz 104:241–245.http://dx.doi.org/10.1590/S0074-0276009000200017.
62. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E, European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). 2008. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2:e277.http://dx.doi.org/10.1371/journal.pntd.0000277.
63. Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, Ten Dam-van Loon N, Muccioli C, Hovakimyan A, Barisani-Asenbauer T, International Ocular Toxoplasmosis Research Group. 2008. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol 146:856–865.e2.http://dx.doi.org/10.1016/j.ajo.2008.09.006.
64. Sauer A, de la Torre A, Gomez-Marin J, Bourcier T, Garweg J, Speeg-Schatz C, Candolfi E. 2011. Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America. Pediatr Infect Dis J 30:601–603.http://dx.doi.org/10.1097/INF.0b013e3182129e70.
65. Grigg ME, Ganatra J, Boothroyd JC, Margolis TP. 2001. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184:633–639.http://dx.doi.org/10.1086/322800.
66. Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort R, Jr., Vitor RW, Silveira C, Sibley LD. 2006. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 12:942–949.http://dx.doi.org/10.3201/eid1206.060025.
67. Switaj K, Master A, Borkowski PK, Skrzypczak M, Wojciechowicz J, Zaborowski P. 2006. Association of ocular toxoplasmosis with type I Toxoplasma gondii strains: direct genotyping from peripheral blood samples. J Clin Microbiol 44:4262–4264.http://dx.doi.org/10.1128/JCM.01786-06.
68. Vallochi AL, Muccioli C, Martins MC, Silveira C, Belfort R, Jr, Rizzo LV. 2005. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol 139:350–351.http://dx.doi.org/10.1016/j.ajo.2004.07.040.
69. McLeod R, Boyer KM, Lee D, Mui E, Wroblewski K, Karrison T, Noble AG, Withers S, Swisher CN, Heydemann PT, Sautter M, Babiarz J, Rabiah P, Meier P, Grigg ME, Toxoplasmosis Study Group. 2012. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981–2009). Clin Infect Dis 54:1595–1605.http://dx.doi.org/10.1093/cid/cis258.
70. Elbez-Rubinstein A, Ajzenberg D, Dardé ML, Cohen R, Dumètre A, Yera H, Gondon E, Janaud JC, Thulliez P. 2009. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 199: 280–285.http://dx.doi.org/10.1086/595793.
71. Valdès V, Legagneur H, Watrin V, Paris L, Hascoët JM. 2011. Congenital toxoplasmosis due to maternal reinfection during pregnancy. Arch Pediatr 1 8:761–763. http://dx.doi.org/10.1016/j.arcped.2011.04.011.
72. Dardé ML, Bouteille B, Pestre-Alexandre M. 1992. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J Parasitol 78:786–794.http://dx.doi.org/10.2307/3283305.
73. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205:625–640.http://dx.doi.org/10.1084/jem.20071641.
74. Cui W, Kaech SM. 2010. Generation of effector CD8_ T cells and their conversion to memory T cells. Immunol Rev 236:151–166.http://dx.doi.org/10.1111/j.1600-065X.2010.00926.x.
75. Baron V, Bouneaud C, Cumano A, Lim A, Arstila TP, Kourilsky P, Ferradini L, Pannetier C. 2003. The repertoires of circulating human CD8(_) central and effector memory T cell subsets are largely distinct. Immunity 18:193–204.http://dx.doi.org/10.1016/S1074-7613(03)00020-7.
76. Wilson DC, Grotenbreg GM, Liu K, Zhao Y, Frickel EM, Gubbels MJ, Ploegh HL, Yap GS. 2010. Differential regulation of effector- and central-memory responses to Toxoplasma gondii infection by IL-12 revealed by tracking of Tgd057-specific CD8_ T cells. PLoS Pathog 6:e1000815.http://dx.doi.org/10.1371/journal.ppat.1000815.
77. Kirak O, Frickel EM, Grotenbreg GM, Suh H, Jaenisch R, Ploegh HL 2010. Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. Science 328:243–248.http://dx.doi.org/10.1126/science.1178590.
78. Yamamoto M, Ma JS, Mueller C, Kamiyama N, Saiga H, Kubo E, Kimura T, Okamoto T, Okuyama M, Kayama H, Nagamune K, Takashima S, Matsuura Y, Soldati-Favre D, Takeda K. 2011. ATF6_ is a host cellular target of the Toxoplasma gondii virulence factor ROP18. J Exp Med 208:1533–1546.http://dx.doi.org/10.1084/jem.20101660.
79. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, Sibley LD. 2011. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci U S A 108: 9631–9636.http://dx.doi.org/10.1073/pnas.1015338108.
80. Khan A, Behnke MS, Dunay IR, White MW, Sibley LD. 2009. Phenotypic and gene expression changes among clonal type I strains of Toxoplasma gondii. Eukaryot Cell 8:1828–1836.http://dx.doi.org/10.1128/EC.00150-09.
81. Yang N, Farrell A, Niedelman W, Melo M, Lu D, Julien L, Marth GT, Gubbels MJ, Saeij JP. 2013. Genetic basis for phenotypic differences between different Toxoplasma gondii type I strains. BMC Genomics 14: 467.http://dx.doi.org/10.1186/1471-2164-14-467.
82. Dubey JP. 1980. Mouse pathogenicity of Toxoplasma gondii isolated from a goat. Am J Vet Res 41:427–429.
83. Fox BA, Bzik DJ. 2010. Avirulent uracil auxotrophs based on disruption of orotidine-5=-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii. Infect Immun 78:3744–3752.http://dx.doi.org/10.1128/IAI.00287-10.
84. Lim D, Gold DA, Julien L, Rosowski EE, Niedelman W, Yaffe MB, Saeij JP. 2013. Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence. J Biol Chem 288:34968–34980.http://dx.doi.org/10.1074/jbc.M113.523266.
85. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G, Boothroyd JC. 2005. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect Immun 73:695–702.http://dx.doi.org/10.1128/IAI.73.2.695-702.2005.
86. Adomako-Ankomah Y, Wier GM, Borges AL, Wand HE, Boyle JP. 2014. Differential locus expansion distinguishes Toxoplasmatinae species and closely related strains of Toxoplasma gondii. MBio 5(1):e01003-13.http://dx.doi.org/10.1128/mBio.01003-13.
87. Jacquet A, Coulon L, De Nève J, Daminet V, Haumont M, Garcia L, Bollen A, Jurado M, Biemans R. 2001. The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans. Mol Biochem Parasitol 116:35–44.http://dx.doi.org/10.1016/S0166-6851(01)00297-3.
88. Dzierszinski F, Mortuaire M, Cesbron-Delauw MF, Tomavo S. 2000. Targeted disruption of the glycosylphosphatidylinositol-anchored surface antigen SAG3 gene in Toxoplasma gondii decreases host cell adhesion and drastically reduces virulence in mice. Mol Microbiol 37:574–582.http://dx.doi.org/10.1046/j.1365-2958.2000.02014.x.
89. Caetano BC, Bruña-Romero O, Fux B, Mendes EA, Penido ML, Gazzinelli RT. 2006. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice. Hum Gene Ther 17:415–426.http://dx.doi.org/10.1089/hum.2006.17.415.
90. Zheng B, Lu S, Tong Q, Kong Q, Lou D. 2013. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine 31:4578–4584.http://dx.doi.org/10.1016/j.vaccine.2013.07.058.
91. Grover HS, Chu HH, Kelly FD, Yang SJ, Reese ML, Blanchard N, Gonzalez F, Chan SW, Boothroyd JC, Shastri N, Robey EA. 2014. Impact of regulated secretion on antiparasitic CD8 T cell responses. Cell Rep 7:1716–1728.http://dx.doi.org/10.1016/j.celrep.2014.04.031.
92. Melo MB, Nguyen QP, Cordeiro C, Hassan MA, Yang N, McKell R, Rosowski EE, Julien L, Butty V, Dardé ML, Ajzenberg D, Fitzgerald K, Young LH, Saeij JP. 2013. Transcriptional analysis of murine macrophages infected with different Toxoplasma strains identifies novel regulation of host signaling pathways. PLoS Pathog. 9:e1003779.http://dx.doi.org/10.1371/journal.ppat.1003779.
93. Bhadra R, Gigley JP, Weiss LM, Khan IA. 2011. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD- 1–PDL-1 blockade. Proc Natl Acad Sci U S A 108:9196–9201.http://dx.doi.org/10.1073/pnas.1015298108.
94. Ogolla PS, Portillo JA, White CL, Patel K, Lamb B, Sen GC, Subauste CS. 2013. The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen. PLoS Pathog 9:e1003557.http://dx.doi.org/10.1371/journal.ppat.1003557.
95. Andrade RM, Wessendarp M, Gubbels MJ, Striepen B, Subauste CS. 2006. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest 116:2366–2377.http://dx.doi.org/10.1172/JCI28796.
96. Persson EK, Agnarson AM, Lambert H, Hitziger N, Yagita H, Chambers BJ, Barragan A, Grandien A. 2007. Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. J Immunol 179:8357–8365.http://dx.doi.org/10.4049/jimmunol.179.12.8357.
97. Aspinall TV, Guy EC, Roberts KE, Joynson DH, Hyde JE, Sims PF. 2003. Molecular evidence for multiple Toxoplasma gondii infections in individual patients in England and Wales: public health implications. Int J Parasitol 33:97–103.http://dx.doi.org/10.1016/S0020-7519(02)00230-8.
98. Boughattas S, Ayari K, Sa T, Aoun K, Bouratbine A. 2014. Survey of the parasite Toxoplasma gondii in human consumed ovine meat in Tunis City. PLoS One 9:e85044. http://dx.doi.org/10.1371/journal.pone.0085044.
99. Ajzenberg D, Bañuls AL, Tibayrenc M, Dardé ML. 2002. Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups. Int J Parasitol 32:27–38.http://dx.doi.org/10.1016/S0020-7519(01)00301-0.
100. Dubey JP. 2006. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts. Vet Parasitol 140:69–75.http://dx.doi.org/10.1016/j.vetpar.2006.03.018.
101. Lilue J, Müller UB, Steinfeldt T, Howard JC. 2013. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse. Elife 2:e01298.http://dx.doi.org/10.7554/eLife.01298.
102. Virreira Winter S, Niedelman W, Jensen KD, Rosowski EE, Julien L, Spooner E, Caradonna K, Burleigh BA, Saeij JP, Ploegh HL, Frickel EM. 2011. Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it. PLoS One 6:e24434.http://dx.doi.org/10.1371/journal.pone.0024434.
103. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, Saeij JP. 2011. Strain-specific activation of the NF-_B pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 208:195–212.http://dx.doi.org/10.1084/jem.20100717.
104. National Research Council. 2011. Guide to the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.